Industrywide Survey Reveals Centralising Regulatory is Number One Priority for Medtech

March 1, 2023
Business Services

BARCELONA, Spain — 28 Feb. 2023 — New research shows a majority of medtech organizations are taking action to advance …

Ascelia Pharma meets major milestone with patient enrollment completion of Phase 3 Study for Orviglance, novel MRI contrast agent for patients with kidney impairment

February 28, 2023
Business Services

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, …

Johnson & Johnson’s Janssen-Cilag unit gets disappointing ‘restricted’ label for PARP drug in EU

February 28, 2023
Medical Communications

Johnson & Johnson (J&J)’s Janssen-Cilag unit has announced that its fixed-dose combination drug Akeega has been recommended for approval by …

Moderna to pay $400m to US government over new COVID-19 vaccine license

February 28, 2023
Sales and Marketing

Moderna, a leader in the development of COVID-19 vaccines, announced that it has paid the National Institute of Allergy and …

CSL receives positive results from rare disease drug phase 3 trial

February 28, 2023
Research and Development

Biotech company CSL has reported positive results from its phase 3 trial for garadacimab, a monthly treatment for hereditary angioedema …

MHRA’s authority restored following Northern Ireland Brexit deal

February 28, 2023
Medical Communications

The Medicines and Healthcare products Regulatory Agency (MHRA) has been limited to approving medicines in Great Britain (England, Scotland and …

Rare and orphan disease expert Terebellum launches market access guide

February 28, 2023
Business Services

Terebellum, subsidiary of global specialty pharmacy and healthcare solutions organisation AscellaHealth, is launching a strategic guide to help manufacturers bring …

Almirall opens the doors of its R&D centre to the biotech ZeClinics

February 27, 2023
Business Services

BARCELONA, Spain. February 27th 2023 – Almirall, a global biopharmaceutical company focused on skin health, today announced an agreement with …

HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China

February 27, 2023
Business Services

Hong Kong, Shanghai & Florham Park, NJ — Monday, February 27, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces …

CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System

February 27, 2023
Business Services

Cambridge, UK, 27 February 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems …

Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment

February 27, 2023
Business Services

Cambridge, UK, 27 February 2023: Five Alarm Bio (FAB), a drug discovery company focused on novel approaches to anti-aging, announced …

FDA sued by US states over abortion pill access

February 27, 2023
Medical Communications

Attorneys general (AGs) from 12 Democrat-led US states have made complaints to the FDA in an attempt to force the …

Causeway Therapeutics raises £8.75m for tennis elbow research

February 27, 2023
Medical Communications

University of Glasgow spin-out Causeway Therapeutics has announced that it has raised £8.75m from investors, which will fund an international …

AbbVie gains positive CHMP opinion for upadacitinib for the treatment of Crohn’s disease

February 27, 2023
Medical Communications

AbbVie has announced that it has received positive feedback from the EMA’s Committee for Medicinal Products for Human Use (CHMP) …

Merck to appeal EU rejection of COVID-19 drug

February 27, 2023
Medical Communications

Life science giant Merck & Co has announced that it will appeal the EU’s Committee for Medicinal Products for Human …

Incyte Announces Positive CHMP Opinion for Ruxolitinib Cream (Opzelura™) for the Treatment of Non-segmental Vitiligo in Adults and Adolescents

February 24, 2023
Business Services

WILMINGTON, Del. – February 24, 2023 – Incyte (Nasdaq:INCY) today announced that the European Medicines Agency (EMA) Committee for Medicinal …

Automata launches the LINQ platform to fully automate workflows and the transport of labware in every lab space

February 24, 2023
Business Services

24th February 2023 – Automata, a leading automation company powering life science labs to fully automate their workflows, today launches

The Gateway to Local Adoption Series

Latest content